Resources

In this week's Homerun Slides, the cardiovascular benefits of pioglitazone.

Impaired glucose tolerance (IGT) and impaired fasting glycemia (IFG) are categorized as stages in the natural history of disordered carbohydrate metabolism. They occur in all individuals as they progress from normal to diabetes, but since the transition through these states is rapid in type 1 diabetes, they are rarely identified in such individuals. Therefore, nearly all of the literature dealing with IGT and IFG is concerned with issues relating to type 2 diabetes, such as risk of developing type 2 diabetes and CVD.

Some think you can’t be too rich or too thin. A stylish female, type 2 diabetes, 46 years of age came into the office (a weight loss clinic) for a follow up. Everyone was telling her how great she looked. She said she was feeling great and excited because she could fit into clothes she couldn’t fit in the past few years. She lost 9 pounds in three months. She had not been self monitoring her glucose. She was thrilled, but her doctor wasn’t so thrilled, at least not yet. He was concerned her glucose was elevated.

What kind of results have you seen with the use of SGLT-2 inhibitors for your patients? Follow the link to respond.

Reasons may include poor metabolic control and extreme obesity.

A patient that you haven’t seen for several years comes to your clinic for a wellness check-up. Since her last visit, she has gained about 15 pounds (5’6”, BMI 27 kg/m2). Her stage 1 hypertension is controlled with hydrochlorothiazide. As you discuss her weight gain, you learn that she doesn’t get more than 30 minutes a week of physical activity. You decide it would be best to check her A1C. Which of the following information from her history leads you to screen her for type 2 diabetes? Follow the link to respond.

Agent could make transplants more available in patients with type 1 diabetes, improve insulin resistance.

As we all know, it is easy to start out with good intentions to be more active or manage diabetes better, but it’s much more difficult to follow through and stick with such changes so that they become sustainable. While some studies have recently shown that newer devices like the Fitbit can increase physical activity adherence, the real question is, will using the latest health information technologies be motivating enough for most people to continue doing it long-term?

New studies indicate potential class effect in reducing hypertension.

ACCORD trial suggests lowering blood-pressure to a target of <120 mm Hg systolic.